No Data
No Data
Vertex Pharmaceuticals Insider Sold Shares Worth $610,560, According to a Recent SEC Filing
Wall Street Today: Market Ends Wild Political TV Day in the Green
Express News | Vertex Receives Chmp Positive Opinion for Expanded Label for Kaftrio® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations
Express News | EMA's Chmp: Extending Therapeutic Indication of Kaftrio, Kalydeco for Cystic Fibrosis in Patients Aged 2 Yrs and Older With Certain Cftr Mutations
Wall Street Today: Market Decides Down is the Direction
Express News | Live On CNBC, Rob Sechan Announces Sold Vertex Pharmaceuticals
Unlock the Full List